Cogent Biosciences Announces Positive Updated Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
December 08, 2024 12:00 ET | Source: Cogent Biosciences, Inc. 52% ORR…
Three International Federations to have their names updated in the Olympic Charter
04 December 2024 - The Executive Board (EB) of the International Olympic Committee (IOC) is…
Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illuminas Updated Comprehensive Gene Panel Assay, TruSight Oncology 500 v2
Agreement will expand worldwide access and better position Myriad’s GIS as a…